JIP
TARO

Jaffetilchin Investment Partners’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Jaffetilchin Investment Partners’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-3,575
Closed -$397K – 242
2014
Q1 		$397K Sell
3,575
-4,146
-54% -$451K 0.16% 100
2013
Q4 		$764K Buy
+7,721
New +$670K 0.38% 64

Other funds holding TARO

ICM
ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
GCM
Greywolf Capital Management Purchase, New York $67.3M AUM 100.05% 1-Year Est. Return
RCM
Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return
AIM
Assured Investment Management New York $79.5M AUM 115.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Jaffetilchin Investment Partners's TARO Position: Q2 2014 in Review

Jaffetilchin Investment Partners sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q2 2014, closing a stake of 3,575 shares — an estimated $397K sold.

Jaffetilchin Investment Partners first reported a position in TARO in Q4 2013 and held it in 2 quarters. The position peaked at $764K in Q4 2013. 73 funds tracked by Wall St. Rank hold TARO as of Q2 2014.

  • Jaffetilchin Investment Partners reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q2 2014 after selling out during the quarter.
  • Jaffetilchin Investment Partners sold 3,575 Taro Pharmaceutical Industries Ltd. shares in Q2 2014, an estimated $397K.
  • Jaffetilchin Investment Partners first reported a position in Taro Pharmaceutical Industries Ltd. in Q4 2013 and held it in 2 quarters.
  • Jaffetilchin Investment Partners's Taro Pharmaceutical Industries Ltd. position peaked at $764K in Q4 2013.
  • 73 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q2 2014.

Based on Jaffetilchin Investment Partners's 13F filing for Q2 2014, filed 24 Jul 2014.